Dr. Eric Aguiar is a Partner at Thomas, McNerney & Partners. He has 16 years of experience in the biopharmaceutical industry. From 2001 to 2007 he was a Managing Director at HealthCare Ventures. Prior to joining HealthCare Ventures, he was CEO of Genovo, Inc. Dr. Aguiar was an executive at TheraTech, a drug delivery company that was sold to Watson Pharmaceuticals in 1997. He was a Managing Director and Vice President of Philadelphia Ventures in the mid-1990's. Prior board seats have included CardioKine, SkinMedica, Vaxinnate, Metaphore Pharmaceuticals, 3-D Pharmaceuticals, and ThromboSys. He graduated from Harvard Medical School and Cornell University with honors.
Dr. Srinivas Akkaraju is a founding Managing Director of Panorama
Capital and focuses primarily on life sciences investments. Previously, he
was with J.P. Morgan Partners, serving as a Principal, starting in April
2001 and becoming a Partner in January 2005. From 1998 to 2001, Dr.
Akkaraju was in Business and Corporate Development at Genentech, Inc., most
recently as Senior Manager responsible for worldwide partnering activities,
in-licensing of therapeutics, and out-licensing of development projects. In
addition to his business development role, Dr. Akkaraju also served as a
Project Team Leader for one of Genentech's clinical development products.
During this time, he also was a founding member of BioStreet, an online
marketplace for biotech op
|SOURCE Amarin Corporation Plc|
Copyright©2008 PR Newswire.
All rights reserved